280 related articles for article (PubMed ID: 23939888)
1. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
Clancy CJ; Chen L; Hong JH; Cheng S; Hao B; Shields RK; Farrell AN; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5258-65. PubMed ID: 23939888
[TBL] [Abstract][Full Text] [Related]
2. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
[TBL] [Abstract][Full Text] [Related]
3. Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
Shields RK; Nguyen MH; Potoski BA; Press EG; Chen L; Kreiswirth BN; Clarke LG; Eschenauer GA; Clancy CJ
Antimicrob Agents Chemother; 2015 Mar; 59(3):1797-801. PubMed ID: 25534733
[TBL] [Abstract][Full Text] [Related]
4. Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
Clancy CJ; Hao B; Shields RK; Chen L; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2014 Jun; 58(6):3521-5. PubMed ID: 24566172
[TBL] [Abstract][Full Text] [Related]
5. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
Jernigan MG; Press EG; Nguyen MH; Clancy CJ; Shields RK
Antimicrob Agents Chemother; 2012 Jun; 56(6):3395-8. PubMed ID: 22430958
[TBL] [Abstract][Full Text] [Related]
6. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
Landman D; Bratu S; Quale J
J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
[TBL] [Abstract][Full Text] [Related]
7. Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae.
Sun D; Rubio-Aparicio D; Nelson K; Dudley MN; Lomovskaya O
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 29038260
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Genetic Background of KPC-2-Producing
Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
[TBL] [Abstract][Full Text] [Related]
9. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.
Venditti C; Butera O; Meledandri M; Balice MP; Cocciolillo GC; Fontana C; D'Arezzo S; De Giuli C; Antonini M; Capone A; Messina F; Nisii C; Di Caro A
Clin Microbiol Infect; 2021 Jul; 27(7):1040.e1-1040.e6. PubMed ID: 33775814
[TBL] [Abstract][Full Text] [Related]
11. Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains.
Tapalski DV; Timoshkova EV; Petrovskaya TA; Osipkina OV; Karpov IA
Klin Lab Diagn; 2021 May; 66(5):304-309. PubMed ID: 34047517
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
Hagihara M; Crandon JL; Urban C; Nicolau DP
J Antimicrob Chemother; 2013 Jul; 68(7):1616-8. PubMed ID: 23475648
[TBL] [Abstract][Full Text] [Related]
14. Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae.
David S; Wong JLC; Sanchez-Garrido J; Kwong HS; Low WW; Morecchiato F; Giani T; Rossolini GM; Brett SJ; Clements A; Beis K; Aanensen DM; Frankel G
PLoS Pathog; 2022 Jul; 18(7):e1010334. PubMed ID: 35816554
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
[TBL] [Abstract][Full Text] [Related]
17. Effect of Porins and bla
Balabanian G; Rose M; Manning N; Landman D; Quale J
Microb Drug Resist; 2018 Sep; 24(7):877-881. PubMed ID: 29782237
[TBL] [Abstract][Full Text] [Related]
18. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
[TBL] [Abstract][Full Text] [Related]
19. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Joshi P; Shrivastava R; Bhagwat S; Patel M
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
